The FDA has granted breakthrough device designation to a multi-cancer screening test. The test, called SPOT-MAS 10, is designed to screen for multiple types of cancer. However, it is unclear if this test has been cleared or approved by the FDA, as other cancer-related tests and therapies have also been mentioned in recent news.